DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: Implications for outcomes and histologic classification

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 1031-1038

  Díaz García, C Vanesa ^a   Agudo López, Alba ^a   Pérez, Carlos ^a   López Martin, José A ^a   Rodríguez Peralto, J Luis ^a   De Castro, Javier ^b   Cortijo, Ana ^a,e   Martínez Villanueva, Miriam ^a,f   Iglesias, Lara ^a   García Carbonero, Rocío ^c   Vara, Juan A Fresno ^d   Gámez Pozo, Angelo ^d   Palacios, José ^c   Cortés Funes, Hernán ^a   Paz Ares, Luis ^c   Agulló Ortuño, M Teresa ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^e MD ANDERSON CANCER CENTER   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DICER1 ENZYME; DROSHA ENZYME; MICRORNA 16; RIBONUCLEASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA INTERFERENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DEAD-BOX RNA HELICASES; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; RIBONUCLEASE III;

EID: 84877124888     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt022     Document Type: Article

References (37)

1. Jemal,A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
2. Fire,A. et al. (1998) Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
3. Farazi,T.A. et al. (2011) miRNAs in human cancer. J. Pathol., 223, 102-115.
4. Markou,A. et al. (2011) Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin. Chem. Lab. Med., 49, 1591-1603.
5. Lu,J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
6. Iorio,M.V. et al. (2009) MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol., 27, 5848-5856.
7. Mascaux,C. et al. (2009) Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur. Respir. J., 33, 352-359.
8. Landi,M.T. et al. (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin. Cancer Res., 16, 430-441.
9. Liu,X. et al. (2011) Involvement of microRNAs in lung cancer biology and therapy. Transl. Res., 157, 200-208.
10. Fassina,A. et al. (2011) Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest, 140, 1305-1311.
11. Yu,S.L. et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.
12. Showe,M.K. et al. (2009) Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res., 69, 9202-9210.
13. Roa,W. et al. (2010) Identification of a new microRNA expression profile as a potential cancer screening tool. Clin. Invest. Med., 33, E124.
14. Leidinger,P. et al. (2011) Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer, 74, 41-47.
15. Kumar,M.S. et al. (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet., 39, 673-677.
16. Bild,A.H. et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature, 439, 353-357.
17. Okayama,H. et al. (2012) Identification of genes upregulated in ALKpositive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res., 72, 100-111.
18. Nelson,K.M. et al. (2008) MicroRNAs and cancer: past, present, and potential future. Mol. Cancer Ther., 7, 3655-3660.
19. Zhang,L. et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA, 103, 9136-9141.
20. Karube,Y. et al. (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci., 96, 111-115.
21. Merritt,W.M. et al. (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med., 359, 2641-2650.
22. Sand,M. et al. (2010) Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest., 28, 649-653.
23. Chiosea,S. et al. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol., 169, 1812-1820.
24. Chiosea,S. et al. (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res., 67, 2345-2350.
25. Sugito,N. et al. (2006) RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin. Cancer Res., 12, 7322-7328.
26. Horikawa,Y. et al. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin. Cancer Res., 14, 7956-7962.
27. Melo,S.A. et al. (2009) A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet., 41, 365-370.
28. Davis-Dusenbery,B.N. et al. (2010) MicroRNA in cancer: the involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer, 1, 1100-1114.
29. Lee,E.J. et al. (2008) Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA, 14, 35-42.
30. Suzuki,H.I. et al. (2009) Modulation of microRNA processing by p53. Nature, 460, 529-533.
31. Su,X. et al. (2010) TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature, 467, 986-990.
32. Chiosea,S.I. et al. (2008) Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Virchows Arch., 452, 629-635.
33. Ryan,B.M. et al. (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer, 10, 389-402.
34. Garofalo,M. et al. (2011) microRNAs: master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol. Toxicol., 51, 25-43.
35. Bandi,N. et al. (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or downregulated in non-small cell lung cancer. Cancer Res., 69, 5553-5559.
36. Tan,X. et al. (2011) A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin. Cancer Res., 17, 6802-6811.
37. Voortman,J. et al. (2010) MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res., 70, 8288-8298.